These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10269764)

  • 1. Lawful uses of drugs purchased at preferential prices.
    Szeinbach SL; Fink JL
    Hosp Pharm; 1985 Jan; 20(1):24-8. PubMed ID: 10269764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pricing of pharmaceuticals and retail competition under the Robinson-Patman Act.
    Abood RR
    Am J Law Med; 1985; 11(3):293-317. PubMed ID: 3842232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal implications of home health care by nonprofit hospitals.
    Greenberg RB
    Am J Hosp Pharm; 1986 Feb; 43(2):386-91. PubMed ID: 3953602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital resales of pharmaceuticals purchased at discriminatory prices.
    Grauer DW
    Top Hosp Pharm Manage; 1990 May; 10(1):20-33. PubMed ID: 10128541
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacies take uniform price demands to court.
    Moskowitz DB
    J Am Health Policy; 1994; 4(4):24-7. PubMed ID: 10136676
    [No Abstract]   [Full Text] [Related]  

  • 6. Hospital retail pharmacies: new limits.
    Robinson ML
    Hospitals; 1987 Sep; 61(18):26. PubMed ID: 3305297
    [No Abstract]   [Full Text] [Related]  

  • 7. Robinson-Patman update: De Modena v. Kaiser Foundation Health Plan.
    Greenberg RB
    Am J Hosp Pharm; 1985 Jul; 42(7):1572-4. PubMed ID: 4025357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules.
    Scott Morton F
    Rand J Econ; 1997; 28(2):269-90. PubMed ID: 11794358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.S. Supreme Court decision in Jefferson County Pharmaceutical Association v. Abbott Laboratories et al.
    Podell LB
    Am J Hosp Pharm; 1983 Sep; 40(9):1537-8. PubMed ID: 6624759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition is driving down prices of many high-volume pharmaceuticals.
    Kuntz EF
    Mod Healthc; 1983 Dec; 13(12):60-2. PubMed ID: 10264040
    [No Abstract]   [Full Text] [Related]  

  • 11. Federal drug discount program proves tricky for hospitals to navigate.
    Thompson CA
    Am J Health Syst Pharm; 2000 Dec; 57(23):2130, 2134, 2139-40. PubMed ID: 11127690
    [No Abstract]   [Full Text] [Related]  

  • 12. Generics, private-labels may shake stagnant cephalosporin prices.
    Brightbill TC
    Hosp Mater Manage; 1987 Jun; 12(6):3-7. PubMed ID: 10283111
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting Unconscionable Prescription-Drug Prices - Maryland's Anti-Price-Gouging Law.
    Greene JA; Padula WV
    N Engl J Med; 2017 Jul; 377(2):101-103. PubMed ID: 28591520
    [No Abstract]   [Full Text] [Related]  

  • 14. What price hospital drugs?
    Bernstein AH
    Hospitals; 1975 Apr; 49(7):159-62. PubMed ID: 1090504
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence and response to the impact of the Medicaid Drug Rebate Program (OBRA) on hospital pharmacy: a progress report from central Ohio.
    Taylor S; Kucukarslan S; Sherrin T
    Hosp Pharm; 1991 Jul; 26(7):621, 624-5. PubMed ID: 10111796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final notice regarding section 602 of the Veterans Health Care Act of 1992 entity guidelines--PHS. Final notice.
    Fed Regist; 1994 May; 59(92):25110-4. PubMed ID: 10134125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible anticompetitive agreements between brand, generic companies to be studied.
    Landis NT
    Am J Health Syst Pharm; 2000 Dec; 57(23):2140, 2142. PubMed ID: 11127691
    [No Abstract]   [Full Text] [Related]  

  • 18. Legal implications of hospital resales of pharmaceuticals. American Hospital Association Office of General Counsel.
    Am J Hosp Pharm; 1986 Aug; 43(8):1951-7. PubMed ID: 3752135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vendor competition, generic drugs spur drop in pharmaceutical prices.
    Seigner CA
    Mod Healthc; 1985 Oct; 15(21):56, 60-2. PubMed ID: 10317662
    [No Abstract]   [Full Text] [Related]  

  • 20. Portland Retail Druggists Association vs Abbott Laboratories et al, part 1.
    Greenberg RB
    Am J Hosp Pharm; 1976 Jun; 33(6):572-3. PubMed ID: 1274976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.